Nutex Health, Inc. (NUTX) - Stock Analysis
Last updated: Jan 14, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin expansion ⢠Cash generation ⢠Leverage reduced NUTX shows materially stronger profitability, cash generation and liquidity with reduced leverage, but sizable receivables and large noncontrollingâinterest allocations raise collection and shareholderâearnings risks.
Price Behavior
Key Price Behavior Insights: ⢠Recovery trend ⢠Noticeable volatility ⢠Resistance capped Support Level: $167.00 Resistance Level: $186â$190 Over the last month NUTX recovered from about $166.84 to $180.72 but remains volatile and capped by resistance near $186â$190, so favor cautious entries on weakness or wait for a clear breakout above resistance.
Sentiment & News
Key News Insights: ⢠New-state entry ⢠Reopened facility ⢠Strong 2025 gains Nutex Health accelerated expansion and investor engagementâopening new and reopened ER/hospital facilities, posting >400% 2025 gains with a modest recent 3% bump and low volume, and presenting at the J.P. Morgan Healthcare Conference to highlight growth.
AI Summary
Nutex's apparent transformation into a cashâgenerative rollâup is real but materially dependent on continued IDR/arbitration wins and ~75% collections against very large receivablesâmaking the stock an eventâdriven buy that pays off only if collections, payer behavior, and legal/regulatory risk remain favorable. Investors should size positions and require timely confirmation of sustained collection rates and resolved governance/filing issues before adding exposure.
Description
Nutex Health, Inc. is a Houston-based, technology-enabled healthcare services company with two operating segments: a Hospital division that owns and operates 21 facilities across eight states, including micro-hospitals, specialty hospitals and hospital outpatient departments; and a Population Health Management division that manages provider networks and delivers management and administrative support to affiliated hospitals and physician groups. The population health unit also maintains a proprietary cloud platform that consolidates clinical and administrative data from multiple systems to provide a comprehensive view of patients and providers and to support care delivery.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 31 | Jan 7 | NUTX | Nutex Health, Inc. | Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring. | Closed | +8.2% |